Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: Results of the prospective German REACH registry cohort

Clinical Research in Cardiology

Volumn 98, Issue 4, 2009, Pages 249-256

  Zeymer, Uwe ^a   Parhofer, Klaus G ^c   Pittrow, David ^d   Binz, Christiane ^e   Schwertfeger, Markus ^f   Limbourg, Tobias ^b   Röther, Joachim ^g  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e BRISTOL MYERS SQUIBB   (United States)

^f Sanofi   (Germany)

^g KLINIKUM MINDEN   (Germany)

Author keywords

Atherothrombosis; Coronary artery disease; Epidemiology; Peripheral arterial disease; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY DISEASE; ELDERLY CARE; FEMALE; GERMANY; HIGH RISK PATIENT; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; THROMBOSIS;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GERMANY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS;

EID: 63449120072     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0754-1     Document Type: Article

References (35)

1. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 348:1329-1339
2. Antithrombotic 2002 Brit Med J 71
3. JJF Belch EJ Topol G Agnelli M Bertrand RM Califf DL Clement MA Creager JD Easton I Gavin R James P Greenland G Hankey P Hanrath AT Hirsch J Meyer SC Smith F Sullivan MA Weber 2003 Critical issues in peripheral arterial disease detection and management: a call to action Arch Intern Med 163 884 892
4. DL Bhatt PG Steg EM Ohman AT Hirsch Y Ikeda J-L Mas S Goto C-S Liau AJ Richard J Rother PWF Wilson for the RRI 2006 International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 180 189
5. V Bongard JP Cambou G Coppe G Jullien A Vahanian JL Mas 2003 Prevalence and management of patients with a prior history of atherothrombotic disease in primary care in France. Results of the ECLAT1 survey Arch Mal Coeur Vaiss 96 833 840
6. V Bongard JP Cambou A Lezorovcz J Ferreres A Vahanan G Jullen G Coppe M Guerllot MA Herrmann JL Mas 2004 Comparison of cardiovascular risk factors and drug use in 14, 544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease Eur J Cardiovasc Prev Rehabil 11 394 402
7. JP Cambou J Ferrieres O Grenier G Boka C Cantet A Leizorovicz 2003 Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey Ann Cardiol Angeiol (Paris) 52 20 29
8. J Cambou A Leizorovicz M Herrmann J Ferrières 2003 Risk of developing a cardiovascular event in patients with peripheral artery disease: results of the APRES study Int Angiol 22 66
9. R Collins J Armitage S Parish P Sleigh R Peto 2003 MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5,963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2005 2016
10. MH Criqui 2001 Peripheral arterial disease-epidemiological aspects Vasc Med 6 3 7
11. C Diehm A Schuster H Allenberg H Darius R Haberl S Lange D Pittrow B von Stritzky G Tepohl H Trampisch 2004 High prevalence of peripheral arterial disease and comorbidity in 6, 880 primary care patients: cross sectional study Atherosclerosis 172 95 105
12. C Diehm S Lange H Darius D Pittrow B von Stritzky G Tepohl RL Haberl JR Allenberg B Dasch HJ Trampisch 2006 Association of low ankle brachial index with high mortality in primary care Eur Heart J 27 1743 1749
13. C Dumas S Sedighian P Nangou Y Boukriche B Simorre E Oziol JL Reny 2007 Medical treatment in peripheral arterial disease: a professional practice study in 262 patients Rev Med Interne 28 71 78
14. HH Feringa SE Karagiannis R Vidakovic A Elhendy O Schouten E Boersma JJ Bax D Poldermans 2007 Glycemic control, lipid-lowering treatment, and prognosis in diabetic patients with peripheral atherosclerotic disease Ann Vasc Surg 21 780 789
15. Gohlke 2005 Z Kardiol 94 III
16. SM Grundy JI Cleeman CN Merz HB Brewer Jr LT Clark DB Hunninghake RC Pasternak SC Smith Jr NJ Stone 2004 Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 227 239
17. CL Heald FG Fowkes GD Murray JF Price 2006 Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review Atherosclerosis 189 61 69
18. AT Hirsch MH Criqui D Treat-Jacobson JG Regensteiner MA Creager JW Olin SH Krook DB Hunninghake AJ Comerota ME Walsh MM McDermott WR Hiatt 2001 Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 1317 1324
19. AT Hirsch Z Haskal N Hertzer 2006 ACC/AHA Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) Circulation 113 463 654
20. Hirsch 2007 Eur Heart J 28 757
21. S Khan M Flather R Mister N Delahunty G Fowkes A Bradbury G Stansby 2007 Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry Eur J Vasc Endovasc Surg 33 442 450
22. Mahoney 2007 Eur Heart J 28 682
23. MM McDermott EA Hahn P Greenland D Cella JK Ockene D Brogan WH Pearce AT Hirsch K Hanley L Odom S Khan MH Criqui MS Lipsky S Hudgens 2002 Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey J Gen Intern Med 17 895 904
24. MM McDermott AL Mandapat A Moates M Albay E Chiou L Celic P Greenland 2003 Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease Arch Intern Med 163 2157 2162
25. MM McDermott JM Guralnik L Ferrucci L Tian K Liu Y Liao D Green R Sufit F Hoff T Nishida L Sharma WH Pearce JR Schneider MH Criqui 2008 Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication Circulation 117 2484 2491
26. JM Murabito JC Evans MG Larson K Nieto D Levy PWF Wilson 2003 The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham study Arch Intern Med 163 1939 1942
27. J Ness WS Aronow E Newkirk D McDanel 2005 Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic J Gerontol A Biol Sci Med Sci 60 255 257
28. L Norgren W Hiatt J Dormandy M Nehler K Harris F Fowkes 2007 Inter-society consensus for the management of peripheral arterial disease (TASC II) Eur J Vasc Endovasc Surg 33 S1 S75
29. TR Pedersen J Kjekshus K Pyorala AG Olsson TJ Cook TA Musliner JA Tobert T Haghfelt 1998 Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S) Am J Cardiol 81 333 335
30. Pittrow 2003 Int J Clin Pharmacol Ther 41 23
31. PG Steg DL Bhatt PW Wilson R D'Agostino Sr EM Ohman J Rother CS Liau AT Hirsch JL Mas Y Ikeda MJ Pencina S Goto 2007 One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 297 1197 1206
32. SR Steinhubl DJ Moliterno 2005 The role of the platelet in the pathogenesis of atherothrombosis Am J Cardiovasc Drugs 5 399 408
33. F Youssef P Gupta DP Mikhailidis G Hamilton 2005 Risk modification in patients with peripheral arterial disease: a retrospective survey Angiology 56 279 287
34. S Yusuf P Sleight J Pogue J Bosch R Davies G Dagenais 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators N Engl J Med 342 145 153
35. Zeymer 2008 Dtsch Ärztebl 105 769